Roland B. Walter, MD, PhD, MS
Walter, Roland
Fred Hutchinson Cancer Center, Seattle, WA
Online Profile:
treatment
Guillermo Sanz, MD, PhD
Sanz, Guillermo
Health Research Institute La Fe, Valencia, Spain
Living with MDS: A Patient Panel
Ask the MDS Expert
Dr. Sandrine Niyongere will gives a brief MDS overview and then answer questions from participants. This interactive webinar recorded patients asking questions that are answered directly by a MDS Expert. #MDS #myelodysplasia #bloodcancer
Understanding Integrative, Holistic and Functional Medicine
Dr. Mikhail Kogan, Medical Director of the GW Center for Integrative Medicine, discusses the differences between integrative, holistic and functional medicines and how they can be used to treat patients. The end of the webinar features questions from patients in the audience.
Effective treatment of low risk acute GVHD with itacitinib monotherapy
Key Points
Itacitinib monotherapy is as effective as systemic corticosteroids for the treatment of low risk acute GVHD.
Itacitinib monotherapy resulted in fewer serious infections compared to systemic corticosteroids.
George Chen, MD
Chen, George
Associate Professor of Oncology at Roswell Park Cancer Center and Associate Professor of Medicine at Jacobs School of Medicine and Biomedical Sciences
Roswell Park Cancer Center
Dr. George Chen is an Associate Professor of Oncology at Roswell Park Cancer Center and associate professor of medicine at Jacobs School of Medicine and Biomedical Sciences. State University of New York at Buffalo. He completed his residency and a fellowship in Houston, TX at Baylor College of medicine and an additional fellowship in Palo Alto, CA at Stanford University. He is board certified in internal medicine, hematology and medical oncology. Dr.
Online Profile:
PNH Experts Discuss: What's Next for PNH? Brief session at the 2022 Patient and Family Hybrid Conference
Transplant for Aplastic Anemia, MDS, and PNH from the 2022 Buffalo Patient and Family Hybrid Conference
Has a bone marrow transplant been suggested as a treatment for
Living Well with Bone Marrow Failure Disease from the 2022 Buffalo Patient and Family Conference
Megan Pailler, PhD, Assistant Professor of Oncology, provides clinical assessment and intervention services to oncology patients on both an inpatient and outpatient basis. Her area of focus has been the hematological services, including leukemia, lymphoma, and bone marrow transplant, providing interventions for patients throughout the spectrum of transplant as an integrated member of the treatment team.